SANASana Biotechnology, Inc.
NAS · US · Healthcare · Biotechnology · sana.com
3.265USD+2.19%Mkt Cap: 897.49M USDP/E: Last update: 2026-06-01

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with un…

Indicators:|

Key Statistics

Company
Market Cap897.49M USD
Enterprise Value902.64M USD
Revenue (TTM)
Gross Profit
Net Income (TTM)-244.17M USD
Revenue/Share
Last Price3.265 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees142
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-6.13
PEG
EV/EBITDA-5.36
EV/Revenue
P/S
P/B5.47
EPS (TTM)-0.92
EPS (Forward)-0.54
52W Range
2.10026% of range6.550
52W High6.550 USD
52W Low2.100 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-151.77%
ROA-58.57%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-143.83M USD
CapEx (TTM)938.00K USD
FCF Margin
FCF Yield-3.31%
Net Debt-18.51M USD
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity0.49
Current Ratio1.29
Quick Ratio1.17
Book Value/Sh0.6030 USD
Cash/Share0.3630 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)8.571 USD
Target Range7.000 USD12.00 USD
# Analysts7
Ownership
Shares Out.278.29M
Float169.91M
Insiders6.51%
Institutions82.84%
Short Interest
Short Ratio9.9d
Short % Float24.62%
Short % Out.13.82%
Shares Short38.47M
Short (prev mo.)40.88M
Technical
SMA 503.238 (+0.8%)
SMA 2003.862 (-15.5%)
Beta2.18
S&P 52W Chg27.70%
Avg Vol (30d)3.65M
Avg Vol (10d)5.58M
Technical Indicators
RSI (14)48.2
MACD-0.0689
MACD Signal-0.0652
MACD Hist.-0.0037
BB Upper3.643 USD
BB Middle3.247 USD
BB Lower2.852 USD
BB Width24.35%
ATR (14)0.2120 USD
Vol Ratio (20d)0.71x